• Join
  • Login
  • Contact

Search abstracts

Counterfeit drug products - example how to address this challenge by applying an holistic approach

  • At: Lisbon (Portugal) (2010)
  • Type: Presentation
  • By: SCHWARZE, Stephan (Bayer Schering Pharma AG Berlin, Berlin, Germany)
  • Abstract:

    The application of single isolated measures to tackle the problem of counterfeit drug products is an insufficient response to the global and fast-growing challenge of counterfeit drug products. Instead an holistic approach as part of risk management is seen to be mandatory to appropriately respond. A conceptual model encompassing the area of


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses